Losartan Potassium
Product Images NDC 68151-0183

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68151-0183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure01 (Figure01)

This appears to be a graph or chart showing the percentage of patients who achieved the primary endpoint in a study of two medications: Atenolol and Losartan potassium. It also includes an adjusted risk reduction percentage and the study duration in months.*

FDA Label Image

Figure02 (Figure02)

This text seems to be a chart or table showing the percentage of patients with fatal/non-fatal stroke for two different medications, Atenolol and Losartan potassium. The adjusted risk reduction is also provided, along with a p-value. The table also includes study months from 6 to 66. Without additional context or information, it is difficult to provide a more detailed description or analysis.*

FDA Label Image

Figure03 (Figure03)

This is a table displaying the results of a study comparing the effectiveness of Losartan K and Atenolol in treating stroke. The data is broken down by age group, gender, race, diabetes status, and history of CVD. The results indicate that Losartan K had a slight advantage over Atenolol in reducing the incidence of primary composite stroke (fatal and non-fatal). The data has been adjusted for baseline Framingham risk score and level of electrocardiographic eft ventricular hypertrophy.*

FDA Label Image

Figure04 (Figure04)

This is a table showing the risk reduction percentage of a drug called Losartan Potassium in comparison to a placebo. The risk reduction achieved by the drug is 16.1% with a significance level of 0.022. However, the context and the event being studied are not available.*

FDA Label Image

Label Image (Lbl681510183)

This is a description of a medication. The medication is listed as "Losartan Potassium," and is in tablet form with a strength of 50 mg. The manufacturer is Teva, and the lot number is LoT89L211. The expiration date is listed as November 2014. The packaging includes a code labeled as UB52914SN19 and a label indicating that it is for prescription use only. The remaining text is not legible due to possible errors.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.